Jim Simons Reata Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $12.6 Million - $22 Million	-134,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $3.74 Million - $5.23 Million	29,600 Added 28.16%	134,700 $21 Million
Q1 2020 May 14, 2020	SELL	$124.16 - $247.74 $17 Million - $33.9 Million	-137,000 Reduced 56.59%	105,100 $15.2 Million
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $18.1 Million - $52.8 Million	242,100 New	242,100 $49.5 Million
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $5.15 Million - $10.1 Million	-99,300 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $4.84 Million - $7.59 Million	99,300 New	99,300 $5.57 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.